Trisenox (arsenic trioxide) is a small molecule pharmaceutical. Arsenic trioxide was first approved as Trisenox on 2000-09-25. It is used to treat promyelocytic leukemia acute in the USA. It has been approved in Europe to treat promyelocytic leukemia acute.
|Common Name||Arsenic trioxide|
|Indication||promyelocytic leukemia acute|
|Drug Class||Antineoplastic agent|